Rahul C Karuturi - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025

Drug DevelopmentPraveen Nekkar Rao, Ahmed Abdallah Hefny, Rahul C Karuturi, et al.

ACS Chemical Neuroscience|February 20, 2026

Combination of Resveratrol and Curcumin with Anti-Amyloid Monoclonal Antibodies Aducanumab and Lecanemab Leads to Greater Inhibition of Amyloid-Beta AggregationWilliam Le Boeuf, Ahmed A Hefny, Rahul C Karuturi, et al.

ACS Medicinal Chemistry Letters|April 16, 2025

Novel Phenoselenazines as Amyloid-β Aggregation InhibitorsAhmed A Hefny, Kartar Singh, Rahul C Karuturi, et al.

Pharmaceuticals (Basel, Switzerland)|January 12, 2021

Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) InfectionPraveen P N Rao, Amy Trinh Pham, Arash Shakeri, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025

Drug DevelopmentPraveen Nekkar Rao, Ahmed Abdallah Hefny, Rahul C Karuturi, et al.

ACS Chemical Neuroscience|February 20, 2026

Combination of Resveratrol and Curcumin with Anti-Amyloid Monoclonal Antibodies Aducanumab and Lecanemab Leads to Greater Inhibition of Amyloid-Beta AggregationWilliam Le Boeuf, Ahmed A Hefny, Rahul C Karuturi, et al.

ACS Medicinal Chemistry Letters|April 16, 2025

Novel Phenoselenazines as Amyloid-β Aggregation InhibitorsAhmed A Hefny, Kartar Singh, Rahul C Karuturi, et al.

Pharmaceuticals (Basel, Switzerland)|January 12, 2021

Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) InfectionPraveen P N Rao, Amy Trinh Pham, Arash Shakeri, et al.

Pageof 1